| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/13/2001 | EP0824525B1 Quinazoline derivatives |
| 06/13/2001 | EP0781279B1 Quinoxalinedione nmda receptor antagonists |
| 06/13/2001 | EP0741722B1 Triazole derivatives |
| 06/13/2001 | EP0727990B1 Compounds, compositions and treatment of allergies and inflammation |
| 06/13/2001 | EP0686034B1 Bisacodyl dosage form |
| 06/13/2001 | EP0675728B1 Products and methods for improving keratinocyte adhesion to the dermis |
| 06/13/2001 | EP0666858B1 5-arylindole derivatives and their use as serotonin (5-ht 1) agonists |
| 06/13/2001 | EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/13/2001 | CN1299369A Plasminogen-related gene B polypeptides |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1299350A Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease characterized by abnormal cell proliferation |
| 06/13/2001 | CN1299348A SPLA inhibitor compounds for treatment of disease |
| 06/13/2001 | CN1299347A Inhibitor of phospholipase enzymes |
| 06/13/2001 | CN1299343A Biphenyl derivatives |
| 06/13/2001 | CN1299342A Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299283A Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
| 06/13/2001 | CN1299282A Vitronectin receptor antagonists |
| 06/13/2001 | CN1299281A Use of oxazolidinone derivative for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 06/13/2001 | CN1299278A Inhibition of angiogenesis |
| 06/13/2001 | CN1299276A CYP2A enzymes and their use in therapeutic and diagnostic method |
| 06/13/2001 | CN1299274A Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 06/13/2001 | CN1299235A Novel composition of eprosartan |
| 06/13/2001 | CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 06/13/2001 | CN1298722A Medicine for treating radiation or cerebroanoxia inadaptation |
| 06/13/2001 | CN1298717A Process for preparing Tibetan medicines |
| 06/13/2001 | CN1067078C 2-beta-alkenyl penam sulfones, prepn. method and use thereof |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067071C Carboline derivatives |
| 06/13/2001 | CN1067068C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1066957C Yin-nourishing, kindney tonifying and yang-strengthening wine and its producing method |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof |
| 06/12/2001 | US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245818 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245802 Method for treating pain |
| 06/12/2001 | US6245791 Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/12/2001 | US6245783 Method of using neurotrophic sulfonamide compounds |
| 06/12/2001 | US6245774 Tri-substituted phenyl or pyridine derivatives |
| 06/12/2001 | US6245766 Method of treating psychiatric conditions |
| 06/12/2001 | US6245763 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease |
| 06/12/2001 | US6245566 Human embryonic germ cell line and methods of use |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/12/2001 | CA2072123C Inhibitors of purine nucleoside phosphorylase |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040263A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040262A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040239A2 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040229A2 Method for producing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | WO2001040218A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040210A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 06/07/2001 | WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001040190A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor |
| 06/07/2001 | WO2001040189A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
| 06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | WO2001040182A2 Solid pharmaceutical preparation |
| 06/07/2001 | WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
| 06/07/2001 | WO2001039805A1 Concomitant drugs for treating glaucoma |
| 06/07/2001 | WO2001039795A2 Attenuation of fibroblast proliferation |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039782A1 Radioprotecting agent |
| 06/07/2001 | WO2001039781A1 Pharmaceutical combinations |
| 06/07/2001 | WO2001039778A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039775A1 Benzimidazole compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039773A1 Thrombopoietin mimetics |
| 06/07/2001 | WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes |
| 06/07/2001 | WO2001039767A1 Tertiary amino compounds having opioid receptor affinity |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |